News

Emyria’s Managing Director, Dr Michael Winlo reflects on a great quarter

February 2, 2021

Emyria’s Managing Director, Dr Michael Winlo reflects on a great quarter in the Appendix 4C ASX Annoucement.

Read the full announcement here

📽️Emyria has received TGA approval for #Openly heart rate monitoring app. MD, Dr mwinlo explains what a Class IIa… https://t.co/ACiY8yZ6Q3

Emyria's MD, mwinlo speaks to proactive_au's AndrewScottTV following the news we have been awarded TGAgovau app… https://t.co/mozma5YUwd

$EMD has received TGAgovau approval for its #Openly app, which will be used in several upcoming clinical trials an… https://t.co/amzORCYikV